Quantum Private Wealth’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Quantum Private Wealth's VKTX Position: Q2 2026 in Review
Quantum Private Wealth reduced its Viking Therapeutics (VKTX) stake by 6.4% in Q2 2026, selling an estimated $219K and leaving 98,365 shares worth $3.84M. The position accounts for 0.98% of the portfolio, ranked #24.
Quantum Private Wealth first reported a position in VKTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.99M in Q1 2024. 435 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Quantum Private Wealth held 98,365 shares of Viking Therapeutics worth $3.84M as of Q2 2026.
- Quantum Private Wealth sold 6,770 Viking Therapeutics shares in Q2 2026, an estimated $219K.
- Viking Therapeutics made up 0.98% of Quantum Private Wealth's portfolio in Q2 2026, its #24 holding.
- Quantum Private Wealth first reported a position in Viking Therapeutics in Q4 2021 and has held it in 19 quarters since.
- Quantum Private Wealth's Viking Therapeutics position peaked at $5.99M in Q1 2024.
- 435 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Quantum Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.